Clinical evaluation of the efficacy and safety of ‘ThriveCo anti-dandruff pre-shampoo treatment,’ containing ZenscalpinTM in the management of scalp dandruff in healthy adults

The study assessed the ThriveCo Anti-Dandruff Pre-Shampoo Treatment, containing Zenscalpin™, in 28 healthy adults over 8 days, showing a 54.79% reduction in dandruff and improvements in scalp dryness, itchiness, redness, and scaliness. The treatment targets fungal overgrowth, inflammation, and skin hydration, with 92.86% of participants reporting reduced dryness and itchiness. The treatment was well-tolerated with no adverse events, suggesting it as a reliable option for daily dandruff management. Key ingredients like witch hazel, piroctone olamine, and niacinamide contribute to its effectiveness by offering anti-inflammatory benefits, combating Malassezia fungus, and fortifying the skin barrier.